{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-105072","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.590199+00:00","generated_at":"2026-05-29T09:57:27.163684+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Onconetix obtains waiver of October payment to Veru; future payment percentage rises to 25%","bullets":["Waives Oct 2024 cash receipt payment due Nov 20, 2024 until Onconetix receives at least $97,000 from Keystone equity line.","In exchange, Onconetix increases Veru's share of net proceeds from future financings/strategic transactions to 25% (from 20%) through June 30, 2025.","Onconetix states it lacks sufficient cash reserves to pay the October Cash Receipt Payments on time.","Amendment executed November 26, 2024; extends forbearance terms under existing April 2024 note agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-105072","json":"https://secwatch.observer/filing/0001213900-24-105072.json","markdown":"https://secwatch.observer/filing/0001213900-24-105072.md","text":"https://secwatch.observer/filing/0001213900-24-105072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/0001213900-24-105072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024105072/ea0223490-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T09:57:27.163684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}